Order Article Reprints

Park CS, Sung MJ, Kim SJ, Jo JH, Lee HS, Chung MJ, Bang S, Park SW, Song SY, Park JY. Prognostic Factors in Patients Treated with Pembrolizumab as a Second-Line Treatment for Advanced Biliary Tract Cancer. Cancers. 2022; 14(17):4323. https://doi.org/10.3390/cancers14174323

Park, Chan Su, Min Je Sung, So Jeong Kim, Jung Hyun Jo, Hee Seung Lee, Moon Jae Chung, Seungmin Bang, Seung Woo Park, Si Young Song, and Jeong Youp Park. 2022. "Prognostic Factors in Patients Treated with Pembrolizumab as a Second-Line Treatment for Advanced Biliary Tract Cancer" Cancers 14, no. 17: 4323. https://doi.org/10.3390/cancers14174323

Park, C. S., Sung, M. J., Kim, S. J., Jo, J. H., Lee, H. S., Chung, M. J., Bang, S., Park, S. W., Song, S. Y., & Park, J. Y. (2022). Prognostic Factors in Patients Treated with Pembrolizumab as a Second-Line Treatment for Advanced Biliary Tract Cancer. Cancers, 14(17), 4323. https://doi.org/10.3390/cancers14174323